IL33 and neoplasm: Meanwhile, we observed a significant decline in the frequency and quantity of ILC2s within the tumor tissues of IL-33−/− tumor-bearing mice, in comparison to WT tumor-bearing mice (Fig. 3D–F and Supplementary Fig. 5A–D).